Silibinin ameliorates STZ-induced impairment of memory and learning by up- regulating insulin signaling pathway and attenuating apoptosis
- 1 January 2020
- journal article
- research article
- Published by Elsevier in Physiology & Behavior
- Vol. 213, 112689
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Type 2 Diabetes as a Risk Factor for Alzheimer's Disease: The Confounders, Interactions, and Neuropathology Associated With This RelationshipEpidemiologic Reviews, 2013
- What have we learned from the streptozotocin-induced animal model of sporadic Alzheimer’s disease, about the therapeutic strategies in Alzheimer’s researchJournal of Neural Transmission, 2012
- An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer’s disease–associated Aβ oligomersJournal of Clinical Investigation, 2012
- Insulin resistance in the nervous systemTrends in Endocrinology & Metabolism, 2012
- Brain insulin signaling: A key component of cognitive processes and a potential basis for cognitive impairment in type 2 diabetesNeurobiology of Learning and Memory, 2011
- Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumoursBritish Journal of Cancer, 2010
- Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: A model for type 2 diabetes and pharmacological screeningPharmacological Research, 2005
- Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic ratKidney International, 2002
- Is sporadic Alzheimer disease the brain type of non-insulin dependent diabetes mellitus? A challenging hypothesisJournal of Neural Transmission, 1998
- Intracerebroventricular administration of streptozotocin causes long-term diminutions in learning and memory abilities and in cerebral energy metabolism in adult rats.Behavioral Neuroscience, 1998